Multi-center prospective study about the clinical significance of the measurement of faecal calprotectin for inflammatory bowel disease.
Not Applicable
- Conditions
- inflammatory bowel diseases
Recruitment & Eligibility
- Status
- OTHER
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Patients with IBD who performed ileocolonoscopy
Exclusion Criteria
imcomplete colonoscopy, difficulty to collect fecal sample,stoma, and so on
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fecal calprotectin, clinical activity index, endoscopic activity index(UC:sum of Mayo endoscopic subscore, CD:SES-CD)
- Secondary Outcome Measures
Name Time Method Evaluation of both fecal calprotectin and endoscopic activity as a predicting marker of relapse in patients with clinical remission of IBD.